Luca Fischer

<scp>Real‐world</scp> experience among patients with relapsed/refractory mantle cell lymphoma after Bruton tyrosine kinase inhibitor failure in Europe: The <scp>SCHOLAR</scp>‐2 retrospective chart review study

Martin Dreyling, Lucie Obéric, Eva Giné et al. · British Journal of Haematology · 2022 · 44 citations · Full text

Medicine, Hematology, Oncology +15

Efficacy comparison of tisagenlecleucel vs usual care in patients with relapsed or refractory follicular lymphoma

Gilles Salles, Stephen J. Schuster, Martin Dreyling et al. · Blood Advances · 2022 · 43 citations · Full text

Medicine, Hematology, Oncology +16

A Retrospective Cohort Study of Treatment Outcomes of Adult Patients With Relapsed or Refractory Follicular Lymphoma (ReCORD-FL)

Gilles Salles, Stephen J. Schuster, Luca Fischer et al. · HemaSphere · 2022 · 29 citations · Full text

Medicine, Oncology, Chemotherapy +15

Indirect treatment comparison of brexucabtagene autoleucel (ZUMA-2) versus standard of care (SCHOLAR-2) in relapsed/refractory mantle cell lymphoma

Martin Dreyling, Lucie Obéric, Eva Giné et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2023 · 13 citations · Full text

Medicine, Oncology, Pharmacotherapy +16